Subjects requiring coronary revascularization with Drug Eluting Stents (DES) coronary revascularization Drug Eluting Stents (DES) The Limus Eluting Orsiro Stent
Conditions
Interventions
All-
comers patient population with the Limus Eluting Orsiro Stent System.
Supportive Care
The patient with the Limus Eluting Orsiro Stent System
Sponsors
faculty of medicine, chiangmai university
faculty of medicine,
chiangmai university
Eligibility
Sex/Gender
All
Age
21 Years to No maximum
Inclusion criteria
Inclusion criteria: - Symptomatic coronary artery disease - Subject signed informed consent for data release - Subject is willing to participate at all follow up assessments - Subject is ≥ 21 years of age
Exclusion criteria
Exclusion criteria: - Subject did not sign informed consent for data release - Known intolerance to aspirin, clopidogrel, ticlopidine, heparin or any other anticoagulation / antiplatelet therapy required for PCI, stainless steel, Sirolimus or contrast media - Planned surgery within 6 months of PCI unless dual antiplatelet therapy will be maintained - Pregnancy - Currently participating in another study and primary endpoint is not reached yet.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Target Lesion Failure (TLF) at 12 months 12 months Event of cardiac death, Myocardial Infarction (MI), Coronary Artery Bypass Graft (CABG), clinically | — |
Secondary
| Measure | Time frame |
|---|---|
| TLF at 6 months follow up 6 months Clinically driven Target Lesion Revascularization (TLR),Target Vessel Revascularization (TVR) 6 months and 12 months event of Vessel Revascularization ,Target Lesion Revascularization (TLR) at 6 and 12 months Event of lesion revascularization,Stent Thrombosis at 6 and 12 months event Stent Thrombosis ,Clinical Device Success Day 0 number of Clinical Device Success,Clinical Procedural Success Day 0 number of Clinical Procedural Success | — |
Countries
Thailand
Contacts
Public ContactPannipa Suwannasom
Faculty of Medicine, Chiang Mai University
Outcome results
None listed